Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic
| Autor: | Luca Saragoni, Edgardo Contato, Elena Pacella, Luca Morelli, Elda Feyles, Mattia Barbareschi, Gerardo Ferrara, Maria Paola Mariani, Ezio Venturino, Ludovica De Vincentiis, Andrea Ambrosini-Spaltro, Enrico Orvieto, Valentina Bertolini, Filippo Crivelli |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Delayed Diagnosis Colorectal cancer Physical Distancing Malignancy 03 medical and health sciences 0302 clinical medicine Prostate Internal medicine Neoplasms medicine Humans 030212 general & internal medicine Pandemics Early Detection of Cancer Bladder cancer business.industry Cancer COVID-19 Anatomical pathology General Medicine medicine.disease medicine.anatomical_structure Italy 030220 oncology & carcinogenesis Histopathology Skin cancer business |
| Zdroj: | American Journal of Clinical Pathology |
| ISSN: | 1943-7722 0002-9173 |
| DOI: | 10.1093/ajcp/aqaa177 |
| Popis: | Objectives We performed data collection concerning the coronavirus disease 2019 (COVID-19) pandemic-related delay in the diagnosis of cancers to individuate proper corrective procedures. Methods A comparison was made among the number of first pathologic diagnoses of malignancy made from weeks 11 to 20 of 2018, 2019, and 2020 at seven anatomic pathology units serving secondary care hospitals in northern-central Italy. Results Cancer diagnoses fell in 2020 by 44.9% compared with the average number recorded in 2018 and 2019. Melanoma and nonmelanoma skin cancer represented 56.7% of all missing diagnoses. The diagnostic decrease in colorectal (–46.6%), prostate (–45%), and bladder (–43.6%) cancer was the most relevant among internal malignancies; for prostate, however, high-grade tumors were only moderately affected (–21.7%). Conclusions Diagnosis of cutaneous malignancies was mostly affected by the lockdown; among internal malignancies, corrective actions were mostly needed for colorectal cancer and invasive bladder cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|